EECPA® treatment promises to be one of the more important changes we have seen in the fight against heart disease. If EECPA® treatment can improve collateral flow and stimulate a natural bypass of obstructed vessels, I believe it will become basic therapy for coronary artery disease patients. It's just a matter of extending the experience to a greater number of cardiologists."

Watch the "Futures Renewed" video, an unscripted patient video from Vasomedical Inc.